2seventy bio, Inc.

TSVT · NASDAQ
Analyze with AI
3/31/2025
12/31/2024
9/30/2024
6/30/2024
Operating Activities
Net Income$482-$19,520-$9,933$24,879
Dep. & Amort.$1,638$1,655$1,658$1,676
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,227$2,438$2,643$2,385
Change in WC-$14,567$7,125-$3,779-$2,359
Other Non-Cash-$753-$1,172-$1,094-$49,723
Operating Cash Flow-$10,973-$9,474-$10,505-$23,142
Investing Activities
PP&E Inv.$0$0-$34-$61
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$23,014-$83,044-$4,843
Inv. Sales/Matur.$32,000$44,000$42,005$40,500
Other Inv. Act.$7,627$1,003-$424$42,842
Investing Cash Flow$39,627$21,989-$41,497$78,438
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0-$24
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$500$3$52$0
Financing Cash Flow$500$3$52-$24
Forex Effect$0$0$0$0
Net Chg. in Cash$29,154$12,518-$51,950$55,272
Supplemental Information
Beg. Cash$72,865$60,347$112,297$57,025
End Cash$102,019$72,865$60,347$112,297
Free Cash Flow-$10,973-$9,474-$10,539-$23,203
2seventy bio, Inc. (TSVT) Financial Statements & Key Stats | AlphaPilot